Stephanie Jarvi Steele1, Todd J Farchione2, Clair Cassiello-Robbins3, Amantia Ametaj4, Sophia Sbi5, Shannon Sauer-Zavala6, David H Barlow7. 1. Boston University, Center for Anxiety and Related Disorders, 648 Beacon Street, 6th Floor, Boston, MA, 02215, USA. Electronic address: sjsteele@bu.edu. 2. Boston University, Center for Anxiety and Related Disorders, 648 Beacon Street, 6th Floor, Boston, MA, 02215, USA. Electronic address: tfarchio@bu.edu. 3. Boston University, Center for Anxiety and Related Disorders, 648 Beacon Street, 6th Floor, Boston, MA, 02215, USA. Electronic address: ccassiel@bu.edu. 4. Boston University, Center for Anxiety and Related Disorders, 648 Beacon Street, 6th Floor, Boston, MA, 02215, USA. Electronic address: amantiaa@bu.edu. 5. Boston University, Center for Anxiety and Related Disorders, 648 Beacon Street, 6th Floor, Boston, MA, 02215, USA. Electronic address: ssbi@bu.edu. 6. Boston University, Center for Anxiety and Related Disorders, 648 Beacon Street, 6th Floor, Boston, MA, 02215, USA. Electronic address: ssauer@bu.edu. 7. Boston University, Center for Anxiety and Related Disorders, 648 Beacon Street, 6th Floor, Boston, MA, 02215, USA. Electronic address: dhbarlow@bu.edu.
Abstract
OBJECTIVE: This study aimed to examine whether the Unified Protocol (UP), a transdiagnostic cognitive-behavioral therapy for emotional disorders (i.e., anxiety, mood, and related disorders), is efficacious in the treatment of co-occurring emotional disorders compared to established single disorder protocols (SDPs) that target specific disorders (e.g., panic disorder). METHOD: Participants included 179 adults seeking outpatient psychotherapy. Participant age ranged from 18 to 66 years, with an average of 30.66 years (SD = 10.77). The sample was 55% female and mostly Caucasian (83%). Diagnostic assessments were completed with the Anxiety Disorder Interview Schedule (ADIS), and disorder-specific, clinician-rated measures for the comorbid diagnoses of interest. RESULTS: In both treatment conditions, participants' mean number of diagnoses dropped significantly from baseline to posttreatment, and baseline to 12-month follow-up. Additionally, large effects were observed for changes in comorbid generalized anxiety (ESSG: UP = -1.72; SDP = -1.98), social anxiety (ESSG: UP = -1.33, -0.86; SDP = -1.60, -1.54), and depression (ESSG: UP = -0.83; SDP = -0.84). Significant differences were not observed in between-group comparisons. CONCLUSIONS: Results suggest that both the UP and SDPs are efficacious in reducing symptoms of comorbid emotional disorders. The clinical, practical, and cost-effective advantages of transdiagnostic CBT are discussed.
OBJECTIVE: This study aimed to examine whether the Unified Protocol (UP), a transdiagnostic cognitive-behavioral therapy for emotional disorders (i.e., anxiety, mood, and related disorders), is efficacious in the treatment of co-occurring emotional disorders compared to established single disorder protocols (SDPs) that target specific disorders (e.g., panic disorder). METHOD:Participants included 179 adults seeking outpatient psychotherapy. Participant age ranged from 18 to 66 years, with an average of 30.66 years (SD = 10.77). The sample was 55% female and mostly Caucasian (83%). Diagnostic assessments were completed with the Anxiety Disorder Interview Schedule (ADIS), and disorder-specific, clinician-rated measures for the comorbid diagnoses of interest. RESULTS: In both treatment conditions, participants' mean number of diagnoses dropped significantly from baseline to posttreatment, and baseline to 12-month follow-up. Additionally, large effects were observed for changes in comorbid generalized anxiety (ESSG: UP = -1.72; SDP = -1.98), social anxiety (ESSG: UP = -1.33, -0.86; SDP = -1.60, -1.54), and depression (ESSG: UP = -0.83; SDP = -0.84). Significant differences were not observed in between-group comparisons. CONCLUSIONS: Results suggest that both the UP and SDPs are efficacious in reducing symptoms of comorbid emotional disorders. The clinical, practical, and cost-effective advantages of transdiagnostic CBT are discussed.
Authors: N Titov; B F Dear; L G Staples; M D Terides; E Karin; J Sheehan; L Johnston; M Gandy; V J Fogliati; B M Wootton; P M McEvoy Journal: J Anxiety Disord Date: 2015-08-31
Authors: M K Shear; T A Brown; D H Barlow; R Money; D E Sholomskas; S W Woods; J M Gorman; L A Papp Journal: Am J Psychiatry Date: 1997-11 Impact factor: 18.112
Authors: Christopher C Conway; Miriam K Forbes; Kelsie T Forbush; Eiko I Fried; Michael N Hallquist; Roman Kotov; Stephanie N Mullins-Sweatt; Alexander J Shackman; Andrew E Skodol; Susan C South; Matthew Sunderland; Monika A Waszczuk; David H Zald; Mohammad H Afzali; Marina A Bornovalova; Natacha Carragher; Anna R Docherty; Katherine G Jonas; Robert F Krueger; Praveetha Patalay; Aaron L Pincus; Jennifer L Tackett; Ulrich Reininghaus; Irwin D Waldman; Aidan G C Wright; Johannes Zimmermann; Bo Bach; R Michael Bagby; Michael Chmielewski; David C Cicero; Lee Anna Clark; Tim Dalgleish; Colin G DeYoung; Christopher J Hopwood; Masha Y Ivanova; Robert D Latzman; Christopher J Patrick; Camilo J Ruggero; Douglas B Samuel; David Watson; Nicholas R Eaton Journal: Perspect Psychol Sci Date: 2019-03-07
Authors: Saira A Weinzimmer; Amy R Goetz; Andrew G Guzick; Lynn M Hana; Sandra L Cepeda; Sophie C Schneider; Sarah M Kennedy; Gifty N Amos Nwankwo; Catherine C Christian; Ashley M Shaw; Alison Salloum; Asim A Shah; Wayne K Goodman; Jill Ehrenreich-May; Eric A Storch Journal: Community Ment Health J Date: 2022-04-04
Authors: Anna L MacKinnon; Kaeley M Simpson; Marlee R Salisbury; Janelle Bobula; Lara Penner-Goeke; Lindsay Berard; Charlie Rioux; Gerald F Giesbrecht; Ryan Giuliano; Catherine Lebel; Jennifer L P Protudjer; Kristin Reynolds; Shannon Sauer-Zavala; Melanie Soderstrom; Lianne M Tomfohr-Madsen; Leslie E Roos Journal: Front Psychiatry Date: 2022-06-24 Impact factor: 5.435
Authors: David Watson; Holly F Levin-Aspenson; Monika A Waszczuk; Christopher C Conway; Tim Dalgleish; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey A Hobbs; Giorgia Michelini; Brady D Nelson; Martin Sellbom; Tim Slade; Susan C South; Matthew Sunderland; Irwin Waldman; Michael Witthöft; Aidan G C Wright; Roman Kotov; Robert F Krueger Journal: World Psychiatry Date: 2022-02 Impact factor: 79.683
Authors: Shannon Sauer-Zavala; Jay C Fournier; Stephanie Jarvi Steele; Brittany K Woods; Mengxing Wang; Todd J Farchione; David H Barlow Journal: Psychol Med Date: 2020-04-21 Impact factor: 7.723
Authors: Alberto González-Robles; Amanda Díaz-García; Azucena García-Palacios; Pablo Roca; Josep Antoni Ramos-Quiroga; Cristina Botella Journal: J Med Internet Res Date: 2020-07-07 Impact factor: 5.428